Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C I Falkson

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Investigational New Drugs|January 1, 1994
FIVB plus GM-CSF in metastatic colorectal cancerC I Falkson, G Falkson, H C Falkson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2000
Phase II trial of doxorubicin and docetaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: Eastern Cooperative Oncology Group Study E1196J A Sparano, A O'Neill, P L Schaefer, et al.
Oncology|November 1, 1994
Recombinant human erythropoietin in the treatment of cancer-related anaemiaC I Falkson, S Keren-Rosenberg, A Uys, et al.
American Journal of Clinical Oncology|October 22, 1998
A randomized study of radiotherapy alone versus radiotherapy plus 5-fluorouracil and platinum in patients with inoperable, locally advanced squamous cancer of the esophagusC F Slabber, J S Nel, L Schoeman, et al.
American Journal of Clinical Oncology|February 22, 2000
Treatment of squamous cell esophageal cancer with topotecan: an Eastern Cooperative Oncology Group Study (E2293)R F Asbury, S Lipsitz, D Graham, et al.
Investigational New Drugs|November 1, 1992
An extended phase II trial of ifosfamide plus mesna in malignant mesotheliomaG Falkson, M Hunt, E C Borden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1987
Treatment of metastatic breast cancer in premenopausal women using CAF with or without oophorectomy: an Eastern Cooperative Oncology Group StudyG Falkson, R S Gelman, D C Tormey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Group studyC I Falkson, J Ibrahim, J M Kirkwood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
Phase II trial of doxorubicin and paclitaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: an Eastern Cooperative Oncology Group StudyJ A Sparano, P Hu, R M Rao, et al.
American Journal of Clinical Oncology|June 17, 2000
21-day oral etoposide for metastatic breast cancer: a phase II study and review of the literatureT Saphner, E A Weller, D C Tormey, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Investigational New Drugs|January 1, 1994
FIVB plus GM-CSF in metastatic colorectal cancerC I Falkson, G Falkson, H C Falkson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2000
Phase II trial of doxorubicin and docetaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: Eastern Cooperative Oncology Group Study E1196J A Sparano, A O'Neill, P L Schaefer, et al.
Oncology|November 1, 1994
Recombinant human erythropoietin in the treatment of cancer-related anaemiaC I Falkson, S Keren-Rosenberg, A Uys, et al.
American Journal of Clinical Oncology|October 22, 1998
A randomized study of radiotherapy alone versus radiotherapy plus 5-fluorouracil and platinum in patients with inoperable, locally advanced squamous cancer of the esophagusC F Slabber, J S Nel, L Schoeman, et al.
American Journal of Clinical Oncology|February 22, 2000
Treatment of squamous cell esophageal cancer with topotecan: an Eastern Cooperative Oncology Group Study (E2293)R F Asbury, S Lipsitz, D Graham, et al.
Investigational New Drugs|November 1, 1992
An extended phase II trial of ifosfamide plus mesna in malignant mesotheliomaG Falkson, M Hunt, E C Borden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1987
Treatment of metastatic breast cancer in premenopausal women using CAF with or without oophorectomy: an Eastern Cooperative Oncology Group StudyG Falkson, R S Gelman, D C Tormey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Group studyC I Falkson, J Ibrahim, J M Kirkwood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
Phase II trial of doxorubicin and paclitaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: an Eastern Cooperative Oncology Group StudyJ A Sparano, P Hu, R M Rao, et al.
American Journal of Clinical Oncology|June 17, 2000
21-day oral etoposide for metastatic breast cancer: a phase II study and review of the literatureT Saphner, E A Weller, D C Tormey, et al.
Pageof 5